Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07450612 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection

Study acronym: BEACON
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is an multicenter study that will test the diagnostic accuracy of a blood test (i.e., a liquid biopsy) for the diagnosis of colorectal cancer (CRC), advanced adenomas (AAs), as well as Lynch-syndrome associated cancers. Additionally, a pre-planned analysis will evaluate the use of this liquid biopsy as a tool for molecular residual disease monitoring purposes.
Trial Details
NCT Number NCT07450612
Lead Sponsor San Raffaele University
Conditions
(from sponsor)		 Colorectal Cancer, Adenoma Colon, Adenoma Colon Polyp, Colon Adenoma, Colo-rectal Cancer, Colon Disease, Colon Neoplasm, Lynch Syndrome +11 more
Related terms Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Lynch syndrome I (site-specific colonic cancer), Lynch Syndrome II, Turcot syndrome
Enrollment 1,200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov